These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 30193705)

  • 1. Oxytocin and Rodent Models of Addiction.
    Leong KC; Cox S; King C; Becker H; Reichel CM
    Int Rev Neurobiol; 2018; 140():201-247. PubMed ID: 30193705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Multidimensional Therapeutic Potential of Targeting the Brain Oxytocin System for the Treatment of Substance Use Disorders.
    Bowen MT; Neumann ID
    Curr Top Behav Neurosci; 2018; 35():269-287. PubMed ID: 28942596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of oxytocin in alcohol and drug abuse.
    King CE; Gano A; Becker HC
    Brain Res; 2020 Jun; 1736():146761. PubMed ID: 32142721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the Oxytocin System to Treat Addictive Disorders: Rationale and Progress to Date.
    Lee MR; Rohn MC; Tanda G; Leggio L
    CNS Drugs; 2016 Feb; 30(2):109-23. PubMed ID: 26932552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sign tracking predicts cue-induced but not drug-primed reinstatement to methamphetamine seeking in rats: Effects of oxytocin treatment.
    Everett NA; Carey HA; Cornish JL; Baracz SJ
    J Psychopharmacol; 2020 Nov; 34(11):1271-1279. PubMed ID: 33081558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rebalancing the Addicted Brain: Oxytocin Interference with the Neural Substrates of Addiction.
    Bowen MT; Neumann ID
    Trends Neurosci; 2017 Dec; 40(12):691-708. PubMed ID: 29128108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use?
    McGregor IS; Callaghan PD; Hunt GE
    Br J Pharmacol; 2008 May; 154(2):358-68. PubMed ID: 18475254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent updates on incubation of drug craving: a mini-review.
    Li X; Caprioli D; Marchant NJ
    Addict Biol; 2015 Sep; 20(5):872-6. PubMed ID: 25440081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breaking the loop: oxytocin as a potential treatment for drug addiction.
    McGregor IS; Bowen MT
    Horm Behav; 2012 Mar; 61(3):331-9. PubMed ID: 22198308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal Oxytocin Selectively Modulates Social Perception, Craving, and Approach Behavior in Subjects With Alcohol Use Disorder.
    Mitchell JM; Arcuni PA; Weinstein D; Woolley JD
    J Addict Med; 2016; 10(3):182-9. PubMed ID: 27159342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can intranasal oxytocin reduce craving in automated addictive behaviours? A systematic review.
    Houghton B; Kouimtsidis C; Duka T; Paloyelis Y; Bailey A
    Br J Pharmacol; 2021 Nov; 178(21):4316-4334. PubMed ID: 34235724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxytocin and Addiction: Potential Glutamatergic Mechanisms.
    Sundar M; Patel D; Young Z; Leong KC
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33673694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxytocin Modulation of Neural Circuits.
    Mitre M; Minder J; Morina EX; Chao MV; Froemke RC
    Curr Top Behav Neurosci; 2018; 35():31-53. PubMed ID: 28864972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxytocin treatment in the prelimbic cortex reduces relapse to methamphetamine-seeking and is associated with reduced activity in the rostral nucleus accumbens core.
    Everett N; Baracz S; Cornish J
    Pharmacol Biochem Behav; 2019 Aug; 183():64-71. PubMed ID: 31202809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxytocin modulates alcohol-cue induced functional connectivity in the nucleus accumbens of social drinkers.
    Bach P; Reinhard I; Bühler S; Vollstädt-Klein S; Kiefer F; Koopmann A
    Psychoneuroendocrinology; 2019 Nov; 109():104385. PubMed ID: 31362183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental enrichment enhances conditioned place preference to ethanol via an oxytocinergic-dependent mechanism in male mice.
    Rae M; Zanos P; Georgiou P; Chivers P; Bailey A; Camarini R
    Neuropharmacology; 2018 Aug; 138():267-274. PubMed ID: 29908241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxytocin for the treatment of drug and alcohol use disorders.
    Lee MR; Weerts EM
    Behav Pharmacol; 2016 Dec; 27(8):640-648. PubMed ID: 27603752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxytocin, Tolerance, and the Dark Side of Addiction.
    Pedersen CA
    Int Rev Neurobiol; 2017; 136():239-274. PubMed ID: 29056153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early adverse experience and substance addiction: dopamine, oxytocin, and glucocorticoid pathways.
    Kim S; Kwok S; Mayes LC; Potenza MN; Rutherford HJV; Strathearn L
    Ann N Y Acad Sci; 2017 Apr; 1394(1):74-91. PubMed ID: 27508337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Oxytocin Receptor: From Intracellular Signaling to Behavior.
    Jurek B; Neumann ID
    Physiol Rev; 2018 Jul; 98(3):1805-1908. PubMed ID: 29897293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.